Cargando…

Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design

Using the National Institutes of Health (NIH) Stage Model framework, we are conducting a Stage III/IV embedded trial to evaluate the effects of personalized music on agitated behaviors in nursing home (NH) residents with dementia under two research conditions--less pragmatic, more researcher involve...

Descripción completa

Detalles Bibliográficos
Autores principales: McCreedy, Ellen, Gutman, Roee, Rudolph, James, Baier, Rosa, Thomas, Kali, Dvorchak, Faye, Ogarek, Jessica, Mor, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743568/
http://dx.doi.org/10.1093/geroni/igaa057.1570
_version_ 1783624248554684416
author McCreedy, Ellen
Gutman, Roee
Rudolph, James
Baier, Rosa
Thomas, Kali
Dvorchak, Faye
Ogarek, Jessica
Mor, Vincent
author_facet McCreedy, Ellen
Gutman, Roee
Rudolph, James
Baier, Rosa
Thomas, Kali
Dvorchak, Faye
Ogarek, Jessica
Mor, Vincent
author_sort McCreedy, Ellen
collection PubMed
description Using the National Institutes of Health (NIH) Stage Model framework, we are conducting a Stage III/IV embedded trial to evaluate the effects of personalized music on agitated behaviors in nursing home (NH) residents with dementia under two research conditions--less pragmatic, more researcher involvement (Stage III) and more pragmatic, less researcher involvement (Stage IV). We are conducting a three-year trial in 81 NHs, with 27 NHs receiving the intervention per year. Behavior frequency is assessed via resident MDS assessments, staff interviews, and direct observations of residents. During the first year, researchers interview NH staff and observe residents with dementia in 54 randomly selected NHs (27 treatment and 27 control, parallel design). MDS assessments are available for all 81 NHs throughout the three-year study (stepped-wedge design). In the 54 NHs in the parallel design, we compare staff interview and NH-conducted resident assessments and, using multiple imputation methods, we impute staff interview data for eligible residents of all 81 NHs in order to estimate the effect of the intervention under the step-wedge design. There are four key features of this trial: 1) combination of parallel and stepped-wedge designs; 2) equilibrating researcher-collected behavior data to NH-collected behavior data to impute research-collected behavior data for some residents; and 3) simulated resident selection process in control facilities to improve comparisons of effects across treatment groups. This design has the potential to shorten the research timeline by iteratively assessing real-world efficacy and large-scale effectiveness. Our design will inform pragmatic testing of other interventions with limited efficacy evidence.
format Online
Article
Text
id pubmed-7743568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77435682020-12-21 Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design McCreedy, Ellen Gutman, Roee Rudolph, James Baier, Rosa Thomas, Kali Dvorchak, Faye Ogarek, Jessica Mor, Vincent Innov Aging Abstracts Using the National Institutes of Health (NIH) Stage Model framework, we are conducting a Stage III/IV embedded trial to evaluate the effects of personalized music on agitated behaviors in nursing home (NH) residents with dementia under two research conditions--less pragmatic, more researcher involvement (Stage III) and more pragmatic, less researcher involvement (Stage IV). We are conducting a three-year trial in 81 NHs, with 27 NHs receiving the intervention per year. Behavior frequency is assessed via resident MDS assessments, staff interviews, and direct observations of residents. During the first year, researchers interview NH staff and observe residents with dementia in 54 randomly selected NHs (27 treatment and 27 control, parallel design). MDS assessments are available for all 81 NHs throughout the three-year study (stepped-wedge design). In the 54 NHs in the parallel design, we compare staff interview and NH-conducted resident assessments and, using multiple imputation methods, we impute staff interview data for eligible residents of all 81 NHs in order to estimate the effect of the intervention under the step-wedge design. There are four key features of this trial: 1) combination of parallel and stepped-wedge designs; 2) equilibrating researcher-collected behavior data to NH-collected behavior data to impute research-collected behavior data for some residents; and 3) simulated resident selection process in control facilities to improve comparisons of effects across treatment groups. This design has the potential to shorten the research timeline by iteratively assessing real-world efficacy and large-scale effectiveness. Our design will inform pragmatic testing of other interventions with limited efficacy evidence. Oxford University Press 2020-12-16 /pmc/articles/PMC7743568/ http://dx.doi.org/10.1093/geroni/igaa057.1570 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
McCreedy, Ellen
Gutman, Roee
Rudolph, James
Baier, Rosa
Thomas, Kali
Dvorchak, Faye
Ogarek, Jessica
Mor, Vincent
Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title_full Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title_fullStr Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title_full_unstemmed Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title_short Addressing Under-Detection in Minimum Data Set Behavioral Measures Using NIH Stage III/IV Embedded Trial Design
title_sort addressing under-detection in minimum data set behavioral measures using nih stage iii/iv embedded trial design
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743568/
http://dx.doi.org/10.1093/geroni/igaa057.1570
work_keys_str_mv AT mccreedyellen addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT gutmanroee addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT rudolphjames addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT baierrosa addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT thomaskali addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT dvorchakfaye addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT ogarekjessica addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign
AT morvincent addressingunderdetectioninminimumdatasetbehavioralmeasuresusingnihstageiiiivembeddedtrialdesign